BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
0.00 (0.00%)
At close: May 1, 2026, 4:00 PM EDT
4.160
-0.020 (-0.48%)
After-hours: May 1, 2026, 7:43 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $30.29 million as of May 1, 2026. Its market cap has increased by 82.47% in one year.
Market Cap
30.29M
Enterprise Value
-297.95K
1-Year Change
82.47%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $30.29M, an increase of 16.50%. That is a compound annual growth rate of 2.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 30.30M | 126.12% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 32.56M |
| Senti Biosciences Holdings | 31.77M |
| NeuroSense Therapeutics | 31.69M |
| Polyrizon | 29.95M |
| Tvardi Therapeutics | 29.46M |
| Tempest Therapeutics | 29.26M |
| Skye Bioscience | 28.93M |
| Rein Therapeutics | 28.88M |